Sort By:
  • CJC 1295 W DAC (2mg)

    0 out of 5

    CJC-1295 is a synthetic analog of the Growth Hormone-Releasing Hormone. With a substitution of four amino acids, it is more resistant to proteolytic inactivation by dipeptidyl peptidase IV (DPP-IV). When combined with Drug Affinity Complex (DAC), it prolongs its half-life, as well as the duration of action in test subjects.

    Studies in animals (rats, pigs, and dogs) show that serum IGF-I levels increase several days after a single administration of CJC-1295 with DAC. It sustained a dose-dependent stimulation of serum GH and IGF-I levels when injected into healthy subjects at intervals of 1-2 weeks.

    It increases plasma levels of growth hormone from somatotropic cells in the pituitary gland of animal test subjects, without altering its pulsation. It doesn’t inhibit the effects of somatostatin.

  • GHRP2 (5mg)

    5.00 out of 5

    Growth Hormone Releasing Peptide-2 is also known as Pralmorelin or KP-102. It is a new 2nd generation synthetic hexapeptide made up of 6 amino acids.

    It is closely related to GHRP-6, a hexapeptide of an earlier generation, and shares many similar characteristics. However, it has a stronger growth hormone-releasing action than GHRP-6 based on a study on cultured pituitary cells in animal test subjects, which showed a 10-fold increase in GH secretion.

    Studies on animal test subjects suggest that GHRP-2 рlауs а rоlе аѕ аn аgоnіѕt of ghrelin, thе rесеntlу-fоund gut рерtіdе. It stimulates growth hormone secretion, with a slight stimulator effect on Prolactin, ACTH, and Cortisol levels. It also reduces the impact of the hormone somatostatin, which impairs the natural release of growth hormone.

    Consequently, GHRP-2 has been shown to increase growth hormone levels and enhances growth performance in animal test subjects.

  • GHRP6 (5mg)

    0 out of 5

    ABOUT GHRP-6: It belongs in the family of the Growth Hormone secretagogue, meaning that it causes the secretion of growth hormone. It is a synthetic hexapeptide and a met-enkephalin derivative that contains a chain of 6 unnatural D amino acids.

    It has no structural similarity with Growth Hormone Releasing Hormone (GHRH) and works by utilizing specific receptors present in cell cultures of the animal pituitary gland or hypothalamus.

    GHRP-6 has cytoprotective effects that are non-growth Hormone-related which include neuroprotective, cardioprotective, anti-inflammatory as well as hepatoprotective effects.

    Studies in animal test subjects show that GHRP-6 stimulates Ghrelin, “the hunger hormone” through its ghrelin receptor, which in turn signals an increased production of growth hormone (GH) by acting at the level of the pituitary or hypothalamus through a specific receptor different from that of the endogenous Growth Hormone-Releasing Hormone GHRH.

    The four parts of the animal test subjects that demonstrate the role of GHRP-6 include the pituitary gland, central nervous system, liver, and stomach.

  • Ipamorelin (5mg)

    0 out of 5

    The pentapeptide Ipamorelin is classified as a GHRP (growth hormone-releasing peptide), which is similar to GHRP-2, GHRP-6, and Hexarelin in stimulating growth hormone (GH) in animal test subjects.

    It is the mildest alternative to GHRP-2 or GHRP-6, because it has similar effects on test subjects, and doesn’t come with as many of the side effects which are noted when during trials of other Growth Hormone Releasing Peptides.

    Surprisingly, Ipamorelin has not been shown to release adrenocorticotropic hormone (ACTH), prolactin or cortisol in levels significantly different from those observed, following GHRH stimulation.

    Іраmоrеlіn mіmісѕ thе GН rеlеаѕіng рерtіdе (GНRР) ghrеlіn bу bіndіng tо thе GНRР rесерtоrѕ аnd асtіvаtіng GН rеlеаѕе.

    Іn соntrаѕt tо оthеr соmроundѕ thаt асtіvаtе thе ріtuіtаrу GН ѕуѕtеm, ѕuсh аѕ GHRP-2 and -6, Iраmоrеlіn іѕ mоrе ѕеlесtіvе іn іtѕ асtіvаtіоn. It іѕ аlѕо mеtаbоlіzеd ѕlоwеr thаn оthеr GНRРѕ, mаkіng іt mоrе ѕtаblе аnd thеrеbу еffесtіvе fоr lоngеr.

  • MGF (2mg)

    0 out of 5

    Mechano Growth Factor (MGF) is a synthetically manufactured peptide that is an alternative splicing variant of Insulin-like Growth Factor-1 (IGF-1). It serves as a local tissue repair factor that responds to changes in physiological conditions or environmental stimuli inducing muscle cell proliferation. It may function as a neuroprotectant in brain ischemia seen in animal studies.

    The level of growth hormone decreases when animals’ age. Several studies show that intensive exercise may stimulate the release of growth hormone in the presence of MGF. This peptide upregulates protein synthesis and activates satellite cells. It is a potent inducer of muscle hypertrophy in experiments.

    It has a relatively short half-life of only a few minutes and is often modified to Pegylated-Mechano Growth Factor (PEG-MGF), increasing its stability.